Denali Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.

About DNLI

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.

CEO

Ryan J. Watts

CEORyan J. Watts

Employees

445

Employees445

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

445

Employees445

DNLI Key Statistics

Market cap

2.29B

Market cap2.29B

Price-Earnings ratio

-14.18

Price-Earnings ratio-14.18

Dividend yield

—

Dividend yield—

Average volume

1.33M

Average volume1.33M

High today

$16.72

High today$16.72

Low today

$15.40

Low today$15.40

Open price

$15.50

Open price$15.50

Volume

1.35M

Volume1.35M

52 Week high

$33.31

52 Week high$33.31

52 Week low

$14.56

52 Week low$14.56

DNLI News

Yahoo Finance 2d

Is There An Opportunity With Denali Therapeutics Inc.'s 50% Undervaluation? - Yahoo Finance

Key Insights Using the 2 Stage Free Cash Flow to Equity, Denali Therapeutics fair value estimate is US$30.74 Denali Therapeutics is estimated to be 50% underv...

Analyst ratings

88%

of 17 ratings

Buy

88.2%

Hold

11.8%

Sell